LIF will produce metformin to REMEDIAR

LIF will produce eight million tablets of Metformin 500 mg to increase the critical stock of the REMEDIAR Program of the National Health Ministry.

The Program couldn’t take the offer in the last bid announced to buy different medicines because of the expensive price the dealer offered. 

Thus, LIF will deliver four million tablets in March and the rest in May 2013.
Metformin is an oral antidiabetic drug. It is the first-line drug of choice for the treatment of type 2 diabetes, in particular, in overweight and obese people and those with normal kidney function.